Concepedia

Amarjot Kaur

AK

28

Publications

2.3K

Citations

23

H-Index

1999

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bernstein Clinical Research Center

University of Cincinnati

National Jewish Health

University of Colorado Denver

Amarjot Kaur is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunotherapy, and allergy.

Top concepts

Publications per year

1999–2022

28

Publications

28

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

Christopher P. Cannon, Sean Curtis, Garret A. FitzGerald et al. · The Lancet · 2006 · 520 citations

, , +8

Alendronate and Estrogen–Progestin in the Long-Term Prevention of Bone Loss: Four-Year Results from the Early Postmenopausal Intervention Cohort Study: A Randomized, Controlled Trial

Pernille Ravn, Marianne Bidstrup, Richard D. Wasnich et al. · Annals of Internal Medicine · 1999 · 186 citations

Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults

Peter S. Creticos, Jennifer Maloney, David I. Bernstein et al. · Journal of Allergy and Clinical Immunology · 2013 · 167 citations

, , +9

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber

Hendrik Nolte, Jennifer Maloney, Harold S. Nelson et al. · Journal of Allergy and Clinical Immunology · 2015 · 158 citations

, , +13

Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial

Jennifer Maloney, David I. Bernstein, Harold S. Nelson et al. · Annals of Allergy Asthma & Immunology · 2013 · 156 citations

, , +3

Rows per page

1–5 of 28